221 related articles for article (PubMed ID: 7545807)
1. The acute promyelocytic leukaemia-associated PML gene is induced by interferon.
Lavau C; Marchio A; Fagioli M; Jansen J; Falini B; Lebon P; Grosveld F; Pandolfi PP; Pelicci PG; Dejean A
Oncogene; 1995 Sep; 11(5):871-6. PubMed ID: 7545807
[TBL] [Abstract][Full Text] [Related]
2. Role and fate of PML nuclear bodies in response to interferon and viral infections.
Regad T; Chelbi-Alix MK
Oncogene; 2001 Oct; 20(49):7274-86. PubMed ID: 11704856
[TBL] [Abstract][Full Text] [Related]
3. Induction of the pro-myelocytic leukaemia gene by type I and type II interferons.
Heuser M; van der Kuip H; Falini B; Peschel C; Huber C; Fischer T
Mediators Inflamm; 1998; 7(5):319-25. PubMed ID: 9883966
[TBL] [Abstract][Full Text] [Related]
4. Induction of the PML protein by interferons in normal and APL cells.
Chelbi-Alix MK; Pelicano L; Quignon F; Koken MH; Venturini L; Stadler M; Pavlovic J; Degos L; de Thé H
Leukemia; 1995 Dec; 9(12):2027-33. PubMed ID: 8609713
[TBL] [Abstract][Full Text] [Related]
5. Herpes virus induced proteasome-dependent degradation of the nuclear bodies-associated PML and Sp100 proteins.
Chelbi-Alix MK; de Thé H
Oncogene; 1999 Jan; 18(4):935-41. PubMed ID: 10023669
[TBL] [Abstract][Full Text] [Related]
6. Interferon-modulated expression of genes encoding the nuclear-dot-associated proteins Sp100 and promyelocytic leukemia protein (PML).
Grötzinger T; Sternsdorf T; Jensen K; Will H
Eur J Biochem; 1996 Jun; 238(2):554-60. PubMed ID: 8681971
[TBL] [Abstract][Full Text] [Related]
7. Interferon coordinately inhibits the disruption of PML-positive ND10 and immediate-early gene expression by herpes simplex virus.
Taylor JL; Unverrich D; O'Brien WJ; Wilcox KW
J Interferon Cytokine Res; 2000 Sep; 20(9):805-15. PubMed ID: 11032400
[TBL] [Abstract][Full Text] [Related]
8. Promyelocytic leukemia protein mediates interferon-based anti-herpes simplex virus 1 effects.
Chee AV; Lopez P; Pandolfi PP; Roizman B
J Virol; 2003 Jun; 77(12):7101-5. PubMed ID: 12768029
[TBL] [Abstract][Full Text] [Related]
9. PML mediates the interferon-induced antiviral state against a complex retrovirus via its association with the viral transactivator.
Regad T; Saib A; Lallemand-Breitenbach V; Pandolfi PP; de Thé H; Chelbi-Alix MK
EMBO J; 2001 Jul; 20(13):3495-505. PubMed ID: 11432836
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element.
Stadler M; Chelbi-Alix MK; Koken MH; Venturini L; Lee C; Saïb A; Quignon F; Pelicano L; Guillemin MC; Schindler C
Oncogene; 1995 Dec; 11(12):2565-73. PubMed ID: 8545113
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneous nuclear expression of the promyelocytic leukemia (PML) protein in normal and neoplastic human tissues.
Gambacorta M; Flenghi L; Fagioli M; Pileri S; Leoncini L; Bigerna B; Pacini R; Tanci LN; Pasqualucci L; Ascani S; Mencarelli A; Liso A; Pelicci PG; Falini B
Am J Pathol; 1996 Dec; 149(6):2023-35. PubMed ID: 8952536
[TBL] [Abstract][Full Text] [Related]
12. Role of the promyelocytic leukemia protein PML in the interferon sensitivity of lymphocytic choriomeningitis virus.
Djavani M; Rodas J; Lukashevich IS; Horejsh D; Pandolfi PP; Borden KL; Salvato MS
J Virol; 2001 Jul; 75(13):6204-8. PubMed ID: 11390623
[TBL] [Abstract][Full Text] [Related]
13. Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein.
Chelbi-Alix MK; Quignon F; Pelicano L; Koken MH; de Thé H
J Virol; 1998 Feb; 72(2):1043-51. PubMed ID: 9444998
[TBL] [Abstract][Full Text] [Related]
14. Nuclear DNA helicase II is recruited to IFN-alpha-activated transcription sites at PML nuclear bodies.
Fuchsová B; Novák P; Kafková J; Hozák P
J Cell Biol; 2002 Aug; 158(3):463-73. PubMed ID: 12163469
[TBL] [Abstract][Full Text] [Related]
15. Role of promyelocytic leukemia protein in host antiviral defense.
Geoffroy MC; Chelbi-Alix MK
J Interferon Cytokine Res; 2011 Jan; 31(1):145-58. PubMed ID: 21198351
[TBL] [Abstract][Full Text] [Related]
16. Cellular localization, expression, and structure of the nuclear dot protein 52.
Sternsdorf T; Jensen K; Züchner D; Will H
J Cell Biol; 1997 Jul; 138(2):435-48. PubMed ID: 9230084
[TBL] [Abstract][Full Text] [Related]
17. The promyelocytic leukemia (PML) protein suppresses cyclin D1 protein production by altering the nuclear cytoplasmic distribution of cyclin D1 mRNA.
Lai HK; Borden KL
Oncogene; 2000 Mar; 19(13):1623-34. PubMed ID: 10763819
[TBL] [Abstract][Full Text] [Related]
18. PML is essential for multiple apoptotic pathways.
Wang ZG; Ruggero D; Ronchetti S; Zhong S; Gaboli M; Rivi R; Pandolfi PP
Nat Genet; 1998 Nov; 20(3):266-72. PubMed ID: 9806545
[TBL] [Abstract][Full Text] [Related]
19. The transcription coactivator CBP is a dynamic component of the promyelocytic leukemia nuclear body.
Boisvert FM; Kruhlak MJ; Box AK; Hendzel MJ; Bazett-Jones DP
J Cell Biol; 2001 Mar; 152(5):1099-106. PubMed ID: 11238464
[TBL] [Abstract][Full Text] [Related]
20. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.
Ahn MJ; Nason-Burchenal K; Moasser MM; Dmitrovsky E
Oncogene; 1995 Jun; 10(12):2307-14. PubMed ID: 7784078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
